Care
ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.
Meg Barron, managing director of engagement and outreach at Peterson Health Technology Institute, highlights how the organization independently evaluates digital health offerings and its recent report on digital musculoskeletal solutions.
The test kits will be available at seven Walmart stores across the state, and the pilot program will be ongoing until supplies run out.
The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.
Amos Adler, founder and president of MEMOTEXT, discusses how the company builds and commercializes digital engagement tools, its digital app for schizophrenia and psychosis patients, and Canadian vs. U.S. markets for digital therapeutics.
The company's first feature to emerge is its "smart notes." It generates clinical notes for providers based on conversations with Talkspace members.
HIMSS24
Mark Polyak, president of global data management at IPSOS, says LLMs can "talk" to patients about administrative tasks like scheduling, but bias and model compatibility must be addressed before clinical deployments.
Harvard research associate Brian Spisak discusses how a "leadership-first, tech-last" approach can prevent organisations from deploying ticking time bombs.